SLC41A1 and Parkinson disease: At 28 days post-6-OHDA injection, SLC41A1 protein expression was significantly downregulated in both retinas of the PD and PD/MgSO4 groups, while MagT1 and CNNM2 levels showed no significant differences among the groups.